J.P.Morgan And Canaccord Genuity Are Confident That Vertex Pharmaceuticals Incorporated’s CF Drug Will Receive FDA Approval
May 13, 2015 at 08:15 AM EDT
On May 12, the FDA advisory committee recommended that the FDA approve Vertex Pharmaceuticals’ Orkambi therapy to treat cystic fibrosis. Shares of Vertex increased nearly 8% in pre-market trading following the announcement.